Elekta acquires Impac

After announcing its intent to merge in late January, Elekta AB this week finalized its acquisition of Mountain View, Calif.-based Impac Medical Systems Inc. Impac in now a wholly owned subsidiary of Elekta.
   
Under the terms of the agreement and plan of merger, Elekta will pay USD 24.00 in cash for each share of IMPAC common stock outstanding. Impac's common stock is no longer trading on the NASDAQ National Market, Elekta said.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.